Emily M. Cowley’s Insights

176 total results. Page 1 of 15.

Alerts
How a Warning Letter Became a Wellness Playbook
Alerts
FDA Proposes Major Overhaul of GRAS Framework: What Food and Feed Companies Need to Know Now
Alerts
RUO-ined: Five Peptide Vendors Learn That ‘Research Use Only’ Is Not a Legal Strategy
Alerts
There Goes the Sun(screen): FDA Removes PABA and Trolamine Salicylate From OTC Monograph
Alerts
Read My Lipstick: FDA Will Not Certify Cosmetic Facility Registration or Product Listing
Press Release
More than 160 ArentFox Schiff Lawyers Recognized by Best Lawyers 2027
Alerts
The (Pep)Tides Turn: FDA Panel Recommends Six of Seven for Compounding
Alerts
50 Shades of Legally Gray: FDA’s Juicy Peptide Cliffhanger
Alerts
Here Comes the Sun(screen): FDA Greenlights Bemotrizinol as Active Ingredient
Alerts
Gene Editing for Human Therapies Just Got a Shortcut: What the FDA’s New Draft Guidance Means for Your Business
Alerts
Pay(or) Attention, Drug and Device Makers: FDA’s New Guidance for Talking to Health Plans
Alerts
US Supreme Court Restores Access to Mifepristone — For Now*